Back
NovoCure Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
47
NVCR
NovoCure
Last Price:
14.77
Seasonality Move:
6.82%
Sell
48
AGIO
Agios Pharmaceuticals
Last Price:
34.54
Seasonality Move:
2.19%
Sell
47
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $14.78. The Score for NVCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $34.54. The Score for AGIO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $34.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AGIO is experiencing slight selling pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 61.74 | Buy |
| Chaikin Money Flow: | -175369 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.21 - 14.43) | Buy |
| Bollinger Bands (100): | (12.95 - 15.47) | Buy |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.23 | Buy |
| Relative Strength Index (14 RSI): | 74.3 | Buy |
| Chaikin Money Flow: | -13101 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.39 - 32.41) | Buy |
| Bollinger Bands (100): | (23.2 - 31.1) | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.99 | Buy |
| 20-day SMA: | 13.03 | Buy |
| 50-day SMA: | 14.19 | Buy |
| 200-day SMA: | 17.01 | Sell |
| 8-day EMA: | 13.31 | Buy |
| 20-day EMA: | 13.21 | Buy |
| 50-day EMA: | 13.76 | Buy |
| 200-day EMA: | 22.18 | Sell |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.86 | Buy |
| 20-day SMA: | 30.92 | Buy |
| 50-day SMA: | 30.69 | Buy |
| 200-day SMA: | 25.72 | Buy |
| 8-day EMA: | 33.02 | Buy |
| 20-day EMA: | 31.54 | Buy |
| 50-day EMA: | 29.92 | Buy |
| 200-day EMA: | 26.86 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.44 per share, and a decrease next year of $0.20 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.12 per share.
NovoCure Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||